{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:10:58Z","timestamp":1788120658643,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jpsychires.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T03:56:43Z","timestamp":1522987003000},"page":"168-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Alterations of eicosanoids and related mediators in patients with schizophrenia"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3553-0832","authenticated-orcid":false,"given":"Dongfang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-0827","authenticated-orcid":false,"given":"Qingbin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2018.04.002_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/oxfordjournals.schbul.a033363","article-title":"Neurocognitive and social functioning in schizophrenia","volume":"25","author":"Addington","year":"1999","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-8993(94)91268-8","article-title":"Prostaglandin E2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity","volume":"663","author":"Akaike","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jnr.20630","article-title":"Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia","volume":"82","author":"Andersson","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bbalip.2014.11.012","article-title":"Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids","volume":"1851","author":"Astarita","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1440-1681.12825","article-title":"Spectrum evaluation-assisted eicosanoid metabolomics for global eicosanoid profiling in human vascular endothelial cells","volume":"45","author":"Bao","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ygyno.2015.10.021","article-title":"Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors","volume":"140","author":"Buas","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib7","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1194\/jlr.R900004-JLR200","article-title":"Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology","volume":"50","author":"Buczynski","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/cts.12324","article-title":"An untargeted metabolomics analysis of antipsychotic use in bipolar disorder","volume":"8","author":"Burghardt","year":"2015","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib9","doi-asserted-by":"crossref","first-page":"596945","DOI":"10.1155\/2013\/596945","article-title":"Fatty acid desaturase gene polymorphisms and metabolic measures in schizophrenia and bipolar patients taking antipsychotics","volume":"2013","author":"Burghardt","year":"2013","journal-title":"Cardiovasc. Psychiatry Neurol"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-6997(25)06784-5","article-title":"International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes","volume":"46","author":"Coleman","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib11","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.4049\/jimmunol.0901871","article-title":"Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant","volume":"184","author":"Coomes","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0952-3278(98)90109-0","article-title":"Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects","volume":"58","author":"Das","year":"1998","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-511X-2-5","article-title":"Endocannabinoid signalling in the blood of patients with schizophrenia","volume":"2","author":"De Marchi","year":"2003","journal-title":"Lipids Health Dis."},{"issue":"Suppl. l","key":"10.1016\/j.jpsychires.2018.04.002_bib14","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1055\/s-2007-992133","article-title":"Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action","volume":"40","author":"Di Pietro","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15622970701361263","article-title":"Isoprostenes as indicators of oxidative stress in schizophrenia","volume":"10","author":"Dietrich-Muszalska","year":"2009","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-009-1612-6","article-title":"Role of cannabis and endocannabinoids in the genesis of schizophrenia","volume":"206","author":"Fernandez-Espejo","year":"2009","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1013713905833","article-title":"Metabolomics\u2013the link between genotypes and phenotypes","volume":"48","author":"Fiehn","year":"2002","journal-title":"Plant Mol. Biol."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib18","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2005.02.013","article-title":"Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats","volume":"48","author":"Fu","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eurpsy.2017.09.007","article-title":"Regulation of inflammatory pathways in schizophrenia: a comparative study with bipolar disorder and healthy controls","volume":"47","author":"Garcia-Alvarez","year":"2017","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib20","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","article-title":"Dopamine activation of endogenous cannabinoid signaling in dorsal striatum","volume":"2","author":"Giuffrida","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib22","doi-asserted-by":"crossref","first-page":"63890","DOI":"10.18632\/oncotarget.19173","article-title":"Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis","volume":"8","author":"Gong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12888-014-0268-x","article-title":"Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition","volume":"14","author":"Gonzalez-Liencres","year":"2014","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib24","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1021\/acs.analchem.5b03812","article-title":"Globally optimized targeted mass spectrometry: reliable metabolomics analysis with broad coverage","volume":"87","author":"Gu","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1192\/bjp.186.4.275","article-title":"Essential fatty acids and mental health","volume":"186","author":"Hallahan","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molmed.2008.08.005","article-title":"Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology","volume":"14","author":"Harizi","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib27","first-page":"1032","article-title":"Impact of clozapine, N-desmethylclozapine and chlorpromazine on thromboxane production in vitro","volume":"8","author":"Himmerich","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib28","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(77)92228-0","article-title":"Schizophrenia as a prostaglandin deficiency disease","author":"Horrobin","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib29","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1021\/pr5007069","article-title":"Serum metabolomics study and eicosanoid analysis of childhood atopic dermatitis based on liquid chromatography-mass spectrometry","volume":"13","author":"Huang","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1159\/000335793","article-title":"Inhibition of leukotriene receptors boosts neural progenitor proliferation","volume":"28","author":"Huber","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.prostaglandins.2009.06.004","article-title":"Epoxyeicosanoid signaling in CNS function and disease","volume":"91","author":"Iliff","year":"2010","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01255817","article-title":"Elevated plasma prostaglandin E2 levels in schizophrenia","volume":"77","author":"Kaiya","year":"1989","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm1362","article-title":"Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity","volume":"12","author":"Kawano","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib35","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00213-012-2671-7","article-title":"Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain","volume":"222","author":"Kim","year":"2012","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mehy.2016.06.003","article-title":"Possible role of epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders","volume":"93","author":"Lakkappa","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib37","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.4049\/jimmunol.168.7.3402","article-title":"Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter","volume":"168","author":"Lang","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4088\/JCP.09r05268yel","article-title":"Antipsychotic medication and oxidative cell stress: a systematic review","volume":"72","author":"Lepping","year":"2011","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/00048670903487209","article-title":"Increased risk of acute myocardial infarction after acute episode of schizophrenia: 6 year follow-up study","volume":"44","author":"Lin","year":"2010","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib40","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1517\/17425255.2014.922954","article-title":"The emergent role of metabolic phenotyping in dynamic patient stratification","volume":"10","author":"Lindon","year":"2014","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib41","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1021\/acs.jproteome.5b00144","article-title":"Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry","volume":"14","author":"Liu","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.schres.2011.01.018","article-title":"The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia","volume":"128","author":"Martinez-Gras","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.schres.2011.03.006","article-title":"Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: relationship with liver delta6-desaturase expression","volume":"129","author":"McNamara","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib44","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bbi.2011.05.014","article-title":"Anti-inflammatory signaling in schizophrenia","volume":"25","author":"Meyer","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib45","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1460-9568.2011.07774.x","article-title":"Thromboxane receptor activation enhances striatal dopamine release, leading to suppression of GABAergic transmission and enhanced sugar intake","volume":"34","author":"Mitsumori","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib46","series-title":"Multivariate Statistical Methods","author":"Morrison","year":"1976"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.schres.2013.06.013","article-title":"Quantification of endocannabinoids in postmortem brain of schizophrenic subjects","volume":"148","author":"Muguruza","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1388-1981(00)00119-0","article-title":"Phospholipase A(2)s and lipid peroxidation","volume":"1488","author":"Nigam","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib49","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.2174\/092986710791859289","article-title":"Involvement of cytosolic phospholipase A(2), calcium independent phospholipase A(2) and plasmalogen selective phospholipase A(2) in neurodegenerative and neuropsychiatric conditions","volume":"17","author":"Ong","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib50","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1039\/C7FO00403F","article-title":"Effects of omega-3 fatty acid supplementation on the pattern of oxylipins: a short review about the modulation of hydroxy-, dihydroxy-, and epoxy-fatty acids","volume":"8","author":"Ostermann","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.plefa.2017.05.004","article-title":"Oxidative stress reduction related to the efficacy of n-3 polyunsaturated fatty acids in first episode schizophrenia: secondary outcome analysis of the OFFER randomized trial","volume":"121","author":"Pawelczyk","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib52","article-title":"Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: a secondary outcome analysis of the OFFER randomized controlled study","author":"Pawelczyk","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/0269881107083816","article-title":"Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy","volume":"22","author":"Potvin","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2014.03.007","article-title":"A review of analytical methods for eicosanoids in brain tissue","volume":"964","author":"Puppolo","year":"2014","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.04.002_bib55","first-page":"1","article-title":"Targeted metabolomics","author":"Roberts","year":"2012","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.plefa.2003.08.012","article-title":"Phospholipid and eicosanoid signaling disturbances in schizophrenia","volume":"69","author":"Ross","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib57","doi-asserted-by":"crossref","first-page":"M111","DOI":"10.1074\/mcp.M111.014746","article-title":"Targeted proteomics of the eicosanoid biosynthetic pathway completes an integrated genomics-proteomics-metabolomics picture of cellular metabolism","volume":"11","author":"Sabido","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib58","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/1573406411309060002","article-title":"Mechanisms of involvement of eicosanoids and their precursors in the pathophysiology and treatment of schizophrenia","volume":"9","author":"Schmidt","year":"2013","journal-title":"Med. Chem."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib60","article-title":"Omics-based biomarkers: application of metabolomics in neuropsychiatric disorders","volume":"19","author":"Sethi","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib61","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/15622975.2015.1117656","article-title":"Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders","volume":"18","author":"Sethi","year":"2017","journal-title":"World J. World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.plefa.2003.08.008","article-title":"From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?","volume":"69","author":"Skosnik","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib63","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.biopsych.2008.10.018","article-title":"The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia","volume":"65","author":"Song","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib64","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1194\/jlr.M016246","article-title":"Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice","volume":"52","author":"Subramanian","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0753-3322(02)00193-2","article-title":"Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies","volume":"56","author":"Tapiero","year":"2002","journal-title":"Biomed. Pharmacother."},{"issue":"Suppl. l","key":"10.1016\/j.jpsychires.2018.04.002_bib66","first-page":"220","article-title":"The role of eicosanoids in the brain","volume":"17","author":"Tassoni","year":"2008","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0920-9964(00)00007-4","article-title":"Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients","volume":"47","author":"Theodoropoulou","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib68","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2012.08.014","article-title":"A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia","volume":"141","author":"van der Kemp","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib69","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"van Os","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/2042018810375656","article-title":"Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis","volume":"1","author":"Vangaveti","year":"2010","journal-title":"Ther. Adv. Endocrinol. Metab"},{"key":"10.1016\/j.jpsychires.2018.04.002_bib71","first-page":"351","article-title":"Recent developments in neurochemical imaging in schizophrenia: an update","volume":"20","author":"Vyas","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib72","doi-asserted-by":"crossref","first-page":"H867","DOI":"10.1152\/ajpheart.00617.2002","article-title":"Role of serotonin in thromboxane A2-induced coronary chemoreflex","volume":"284","author":"Wacker","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.prostaglandins.2015.04.002","article-title":"Effect of acute and chronic DSS induced colitis on plasma eicosanoid and oxylipin levels in the rat","volume":"120","author":"Willenberg","year":"2015","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib74","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jchromb.2015.05.015","article-title":"A comprehensive quantification method for eicosanoids and related compounds by using liquid chromatography\/mass spectrometry with high speed continuous ionization polarity switching","volume":"995\u2013996","author":"Yamada","year":"2015","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpsychires.2018.04.002_bib75","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prostaglandins.2015.03.005","article-title":"Effects of thyroid hormone status on metabolic pathways of arachidonic acid in mice and humans: a targeted metabolomic approach","volume":"118\u2013119","author":"Yao","year":"2015","journal-title":"Prostag. Other Lipid Mediat."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618300025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618300025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T13:16:28Z","timestamp":1751548588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395618300025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":75,"alternative-id":["S0022395618300025"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.04.002","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations of eicosanoids and related mediators in patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}